PEPTIDESMADE SIMPLE
Synthetic peptide, 15 amino acids

BPC-157

Also called Body Protection Compound-157, PL 14736, Pentadecapeptide BPC 157

From Matthew Farrahi’s Peptide Insights research · Updated October 28, 2026

BPC-157 is a lab-made peptide of 15 amino acids, based on part of a protein that researchers reported finding in human gastric juice. It is one of the most discussed peptides online because of rat studies on tendons, muscles and the gut. Almost all of that research is in animals, and human data are very limited.

Type
Synthetic peptide (15 amino acids)
Origin
Based on a fragment of a protein reported in human gastric juice
Researched for
Tendon, ligament, muscle and gut injury in animals
Evidence so far
Mostly rat studies; a few small, uncontrolled human reports

For education and research only. Not medical advice, and not a recommendation to use anything.

Peptide Insights · 8:34Matthew walks through what BPC-157 is, how it is thought to work, the research behind it and its pros and cons.

What is BPC-157?

BPC stands for body protection compound. Researchers at the University of Zagreb in Croatia described a larger protein in human gastric juice, then made a 15-amino-acid piece of it and named it BPC-157. The peptide used in research is made in a lab. It is often called natural online, but there is little evidence that this exact fragment circulates in the body on its own.

Most published work on BPC-157 comes from that same Croatian group, led by Predrag Sikiric. They describe the peptide as unusually stable in stomach acid, which is why it has been studied both by mouth and by injection in animals. Some work from other labs exists, mainly cell studies, but independent replication is far smaller. That matters when judging how solid the findings are.

How does BPC-157 work?

No one knows for sure. Lab and animal studies point to several possible actions. BPC-157 appears to encourage angiogenesis, the growth of new small blood vessels, partly through the VEGF receptor pathway. It also seems to interact with the nitric oxide system, which helps control blood flow. In tendon cells grown in a dish, researchers reported more cell migration and more growth hormone receptors after exposure to BPC-157.

These are proposed mechanisms, not settled biology. Many were measured in rats or in cells over short experiments. The peptide has not gone through the detailed human testing that approved medicines receive, so how it is absorbed, how long it lasts and what it does in people are still open questions.

Mixing it for research?

BPC-157 reconstitution chart: how much bacteriostatic water to add to a 5 mg or 10 mg vial and how many units each amount is, with Matthew’s step-by-step video.

See the mixing chart

What has research looked at?

Tendons and ligaments
In rat studies, researchers reported faster and better organized healing of damaged Achilles tendons and knee ligaments. Comparable controlled studies in people have not been published.
Muscle
Rat studies of crushed, cut or torn muscle reported better recovery of muscle structure and function in treated animals.
Gut lining
BPC-157 was first studied for stomach ulcers and bowel damage in rats, including damage from alcohol and anti-inflammatory painkillers. Early clinical testing for inflammatory bowel disease was reported under the code PL 14736, but detailed results are hard to find.
Bone
Some animal studies, including work in rabbits, looked at bone defects and reported improved bone repair in treated animals.
Brain and nerves
Rodent studies have explored nerve injury, brain injury and behavior models. These are early findings that have not been tested in people.
Human reports
A small retrospective report from one clinic described people with knee pain who said it improved after receiving BPC-157, and a few other small case series exist. None had a control group, so they cannot show the peptide caused the change.

Taken together, the animal results are plentiful and fairly consistent, but they come mostly from one research group and have not been confirmed by controlled human trials. Scientifically, BPC-157 is still an early-stage research compound, and claims about it in people go well beyond the evidence.

Side effects and cautions

Because there are no large human trials, the side effects of BPC-157 in people are not well defined. Preclinical safety studies in several animal species reported few toxic effects, but animal safety does not establish human safety. Effects people describe online, such as irritation where it was injected, nausea, headache, dizziness or water retention, are anecdotal. Anyone with health questions should talk to a qualified clinician.

Cancer history
BPC-157 appears to promote new blood vessel growth, which tumors also rely on. That is a theoretical concern for anyone with current or past cancer, and it has not been studied.
Pregnancy and breastfeeding
There are no safety data, so this is an unknown.
Long-term effects
No study has followed people using BPC-157 over months or years.
Product content
Peptides sold outside medical settings can differ from their labels in content or purity, a risk that research studies did not measure.

Further reading

This page summarizes the research in plain words. To read the studies yourself:

Free printable PDF

Get the BPC-157 mixing chart as a printable page.

Every vial size on one sheet, plus the reader kit: a lab math worksheet, a lab log and a COA checklist.

Free. We'll send material on the peptides you've viewed here. Unsubscribe anytime. Privacy policy.

BPC-157: questions

Is BPC-157 a steroid?

No. BPC-157 is a short peptide, a chain of 15 amino acids. It is not a hormone and has no steroid structure.

Is BPC-157 natural?

Its sequence is based on part of a protein reported in human gastric juice, but the BPC-157 used in research is made in a lab. There is little evidence that this exact fragment circulates in the body on its own.

Has BPC-157 been tested in humans?

Only in a very limited way. There are a few small, uncontrolled reports and an early clinical program for bowel disease with little published detail. No large randomized trials have been published.

Does BPC-157 cause cancer?

There is no evidence that it does, but it has not been studied for this. Because it appears to promote blood vessel growth, researchers consider it a theoretical concern for people with current or past cancer.

What is BPC-157 researched for?

Mostly tendon, ligament, muscle, bone and gut injuries in rats, plus some early work on nerves and the brain.

Want to go further than the books?

Peptide Academy is Matthew's community on Skool, free to join. Members ask Matthew live every Monday and get the full encyclopedias and courses, updated as the research changes.

  • A live Q&A with Matthew every Monday at 7 pm CT
  • Peptide, combo and reconstitution encyclopedias
  • Peptide Basics 101 and a lab course

Peptide Academy on Skool

Freeto join, no card

Members: $19 a month or $147 a year.

See what's inside
Free printable chartEvery common vial size, plus a lab log
Get it free